The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Drug Therapy
PreviousPrevious
Volume 351:2203-2217 November 18, 2004 Number 21
NextNext

Advances in H1-Antihistamines
F. Estelle R. Simons, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
More than 30,000 peer-reviewed articles on histamine and the H1-antihistamines have been published since this subject was last reviewed in the Journal a decade ago.1 The role of histamine in neurotransmission,2,3,4 allergic inflammation,5,6,7,8,9,10,11,12 and immune modulation9,10,11,12,13,14,15,16,17,18,19 has been further elucidated since that time. The human H1-histamine and H2-histamine receptors were cloned and characterized in the early 1990s,20,21 as were the human H3-histamine and H4-histamine receptors several years ago.22,23

H1-antihistamines, historically known as histamine H1-receptor blockers or antagonists, are specific for the H1-receptor. In addition, some H1-antihistamines inhibit transmission through the muscarinic, {alpha}. . . [Full Text of this Article]

Histamine

Role in Human Health

Allergic Inflammation and Immune Modulation

Types of Histamine Receptors

Basic and Clinical Pharmacology

Inverse Agonism and Classification Systems

Antiallergic and Antiinflammatory Activities

Pharmacokinetics and Pharmacodynamics

Adverse Effects

Efficacy

Allergic Rhinoconjunctivitis

Other Airway Disorders

Urticaria

Other Allergic and Immunologic Disorders

Disorders of the Central Nervous System and Vestibular Disorders

Potential Adverse Effects

Central Nervous System Toxicity

Cardiac Toxicity

Other Adverse Effects and Concerns

Future Directions


Source Information

From the Section of Allergy and Clinical Immunology, Department of Pediatrics and Child Health, Department of Immunology, and the Canadian Institutes of Health Research National Allergy and Asthma Training Program, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.

Address reprint requests to Dr. Simons at 820 Sherbrook St., Winnipeg, MB R3A 1R9, Canada, or at lmcniven@hsc.mb.ca.


Related Letters:

H1-Antihistamines
Lee D. K.C., Currie G. P., Lipworth B. J., Altschuler E. L., Kast R. E., Simons F. E. R.
Extract | Full Text | PDF  
N Engl J Med 2005; 352:1155-1157, Mar 17, 2005. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.